Literature DB >> 28746242

Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use Disorder.

Meghan Gannon1, Michael Mackenzie, Karol Kaltenbach, Diane Abatemarco.   

Abstract

OBJECTIVES: Mothers with opioid use disorder are at high risk for maladaptive parenting. The present observational study aimed to measure the impact of a trauma-informed mindfulness-based parenting (MBP) intervention on quality of parenting behaviors of mothers primarily with opioid use disorders as well as examine associations between exposure to adverse childhood experiences and self-reported mindful parenting.
METHODS: A pretest posttest design was used with repeated measures. A total of 160 women were recruited from a substance use treatment program into the 12-week-long group-based intervention comprised didactic and experiential mindfulness activities. The Keys to Interactive Parenting Scale (KIPS) measured quality of parenting behavior, the Adverse Childhood Experiences Tool captured history of exposure to childhood trauma, and the Interpersonal Mindfulness in Parenting (IM-P) scale measured the degree of mindful parenting. Analyses were conducted using multilevel modeling.
RESULTS: The MBP intervention resulted in clinically significant improvements in KIPS total and all subscale scores and an IM-P total score. Data showed higher baseline Adverse Childhood Experiences and higher program attendance significantly predicted improved overall quality of parenting behaviors at a greater rate over time. Higher IM-P scores were associated with greater rate of improvement in KIPS total and all subscale scores.
CONCLUSIONS: Study findings suggest a trauma-informed MBP intervention for parenting women with opioid use disorders is associated with significant clinical improvements in quality of parenting behavior. Results of this model show promise in supporting parenting of mothers receiving treatment for opioid use disorders to enhance bonding and parenting.

Entities:  

Mesh:

Year:  2017        PMID: 28746242     DOI: 10.1097/ADM.0000000000000336

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  8 in total

1.  Accelerating the Pace of Science: Improving Parenting Practices in Parents with Opioid Use Disorder.

Authors:  Camille C Cioffi; Leslie D Leve; John R Seeley
Journal:  Parent Sci Pract       Date:  2019-06-17

2.  Perceptions of Pediatric Primary Care Among Mothers in Treatment for Opioid Use Disorder.

Authors:  Vanessa L Short; Neera K Goyal; Esther K Chung; Dennis J Hand; Diane J Abatemarco
Journal:  J Community Health       Date:  2019-12

Review 3.  Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.

Authors:  Martha L Velez; Chloe J Jordan; Lauren M Jansson
Journal:  Neurotoxicol Teratol       Date:  2021-08-19       Impact factor: 3.763

4.  DRD4 interacts with adverse life events in predicting maternal sensitivity via emotion regulation.

Authors:  Jinni Su; Esther M Leerkes; Mairin E Augustine
Journal:  J Fam Psychol       Date:  2018-07-23

5.  Well-Child Care Adherence After Intrauterine Opioid Exposure.

Authors:  Neera K Goyal; Jessica F Rohde; Vanessa Short; Stephen W Patrick; Diane Abatemarco; Esther K Chung
Journal:  Pediatrics       Date:  2020-01-02       Impact factor: 7.124

Review 6.  A Literature Review of the Role of Mindfulness Practices in Nutrition for Mothers and Their Children.

Authors:  Samantha Keaulana; Mapuana Antonio; Hailey Schoch; Jinan Banna
Journal:  Am J Lifestyle Med       Date:  2019-08-12

7.  Interpersonal Mindfulness Questionnaire: Scale Development and Validation.

Authors:  Bassam Khoury; Rodrigo C Vergara; Christina Spinelli
Journal:  Mindfulness (N Y)       Date:  2022-03-16

Review 8.  Improving Parenting Practices Among Fathers Who Misuse Opioids: Fathering Through Change Intervention.

Authors:  Camille C Cioffi; David S DeGarmo
Journal:  Front Psychol       Date:  2021-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.